Stay updated on ADVANCE Study of Daratumumab Combo in Myeloma Clinical Trial
Sign up to get notified when there's something new on the ADVANCE Study of Daratumumab Combo in Myeloma Clinical Trial page.

Latest updates to the ADVANCE Study of Daratumumab Combo in Myeloma Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe history shows a new revision (v3.4.2) added and v3.4.1 removed. This update appears to affect only site metadata rather than study data or core content.SummaryDifference0.1%

- Check16 days agoChange DetectedRevision: v3.4.1 was added to the history and Revision: v3.4.0 was removed.SummaryDifference0.1%

- Check38 days agoChange DetectedThe page history shows a new entry for Revision: v3.3.4 and removal of Revision: v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check60 days agoChange DetectedA new revision label 'Revision: v3.3.3' was added to the record history, and the footer no longer displays 'HHS Vulnerability Disclosure' or the previous 'Revision: v3.3.2'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check89 days agoChange DetectedRevision history now shows the latest version as v3.3.2, replacing v3.2.0, which reflects a site version update rather than changes to study data or page content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check96 days agoChange DetectedRemoval of the government funding/operating status banner from the page; this is an administrative notice and does not affect the study record or core content.SummaryDifference0.6%

Stay in the know with updates to ADVANCE Study of Daratumumab Combo in Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ADVANCE Study of Daratumumab Combo in Myeloma Clinical Trial page.